International urology and nephrology
Serum PCSK9 level as a potential biomarker relating to age, cholesterol and predicting major adverse cardiovascular event risk in hemodialysis patients.
Yunxia Li, Wenxiu Chai, Panpan Cai, Ye Xin, Jianbo Shao
Published: 202510.1007/s11255-025-04776-9
Abstract
OBJECTIVE: Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates cholesterol metabolism, vascular inflammation, plaque formation, atherosclerosis, and renal injury. This study aimed to investigate the level of serum PCSK9 and its associatio…
Preview only. Read the full abstract at the source